Medtronic
MDT
1,931 hedge funds and large institutions have $87.7B invested in Medtronic in 2022 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 914 increasing their positions, 707 reducing their positions, and 148 closing their positions.
94% more call options, than puts
Call options by funds: $893M | Put options by funds: $461M
29% more repeat investments, than reductions
Existing positions increased: 914 | Existing positions reduced: 707
3% more funds holding in top 10
Funds holding in top 10: 32 → 33 (+1)
1.45% more ownership
Funds ownership: 80.59% → 82.04% (+1.5%)
5% less funds holding
Funds holding: 2,022 → 1,931 (-91)
8% less capital invested
Capital invested by funds: $95.6B → $87.7B (-$7.91B)
39% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 148
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$505M |
| 2 |
Bank of New York Mellon
New York
|
+$433M |
| 3 |
JP Morgan Chase
New York
|
+$333M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$328M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$305M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$459M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$300M |
| 3 |
Barclays
London,
United Kingdom
|
-$268M |
| 4 |
TAM
Troy Asset Management
London,
United Kingdom
|
-$264M |
| 5 |
Neuberger Berman Group
New York
|
-$257M |
MDT Hedge Fund Activity: Q3 2022 in Review
1,931 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2022, worth a combined $87.7B — down 8.3% from $95.6B a quarter earlier.
Sellers outnumbered buyers: 148 funds closed out of MDT and 90 opened new positions — a net loss of 58 holders — while 707 trimmed existing stakes and 914 added.
The largest buyer was BlackRock, adding an estimated $505M. The largest seller was Franklin Resources, cutting an estimated $459M.
- 1,931 institutional investors held Medtronic (MDT) as of Q3 2022, down from 2,022 in Q2 2022.
- Funds reported $87.7B of Medtronic stock for Q3 2022, down 8.3% quarter-over-quarter.
- 90 funds opened new Medtronic positions in Q3 2022 and 148 closed out, a net change of -58 holders.
- The largest Medtronic buyer in Q3 2022 was BlackRock, an estimated $505M added.
- The largest Medtronic seller in Q3 2022 was Franklin Resources, an estimated $459M sold.
Based on aggregated 13F filings for Q3 2022.